|
1
|
Liu F, Ma YT, Yang YN, Xie X, Li XM, Huang
Y, Ma X, Chen BD, Gao X and Du L: Current status of primary
hypertension in Xinjiang: An epidemiological study of Han, Uygur
and Hazakh populations. Zhonghua Yi Xue Za Zhi. 90:3259–3263.
2010.(In Chinese). PubMed/NCBI
|
|
2
|
Harrison DG, Guzik TJ, Lob HE, Madhur MS,
Marvar PJ, Thabet SR, Vinh A and Weyand CM: Inflammation, immunity,
and hypertension. Hypertension. 57:132–140. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Montecucco F, Pende A, Quercioli A and
Mach F: Inflammation in the pathophysiology of essential
hypertension. J Nephrol. 24:23–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dinh QN, Drummond GR, Sobey CG and
Chrissobolis S: Roles of inflammation, oxidative stress, and
vascular dysfunction in hypertension. Biomed Res Int.
2014:4069602014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Guzik TJ, Hoch NE, Brown KA, McCann LA,
Rahman A, Dikalov S, Goronzy J, Weyand C and Harrison DG: Role of
the T cell in the genesis of angiotensin II induced hypertension
and vascular dysfunction. J Exp Med. 204:2449–2460. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schiffrin EL: T lymphocytes: A role in
hypertension? Curr Opin Nephrol Hypertens. 19:181–186. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu L, Pennington M, Jiang Q, Whartenby KA
and Calabresi PA: Characterization of the functional properties of
the voltage-gated potassium channel Kv1.3 in human CD4+ T
lymphocytes. J Immunol. 179:4563–4570. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wulff H, Calabresi PA, Allie R, Yun S,
Pennington M, Beeton C and Chandy KG: The voltage-gated Kv1.3 K(+)
channel in effector memory T cells as new target for MS. J Clin
Invest. 111:1703–1713. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schmitz A, Sankaranarayanan A, Azam P,
Schmidt-Lassen K, Homerick D, Hänsel W and Wulff H: Design of
PAP-1, a selective small molecule Kv1.3 blocker, for the
suppression of effector memory T cells in autoimmune diseases. Mol
Pharmacol. 68:1254–1270. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang QB, Zhang YM, Cheng LF, Yuan QY,
Zhang GM, Liang P and Gou F: Voltage-dependent potassium channel
and calcium-activated potassium channel current changes of
peripheral blood T-lymphocytes from hypertensive patients in
Xinjiang Kazakh. Zhonghua Xin Xue Guan Bing Za Zhi. 41:1020–1024.
2013.(In Chinese). PubMed/NCBI
|
|
11
|
Sasamura H, Nakazato Y, Hayashida T,
Kitamura Y, Hayashi M and Saruta T: Regulation of vascular type 1
angiotensin receptors by cytokines. Hypertension. 30:35–41. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dorffel Y, Lätsch C, Stuhlmüller B,
Schreiber S, Scholze S, Burmester GR and Scholze J: Preactivated
peripheral blood monocytes in patients with essential hypertension.
Hypertension. 34:113–117. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Omi T, Kumada M, Kamesaki T, Okuda H,
Munkhtulga L, Yanagisawa Y, Utsumi N, Gotoh T, Hata A, Soma M, et
al: An intronic variable number of tandem repeat polymorphisms of
the cold-induced autoinflammatory syndrome 1 (CIAS1) gene modifies
gene expression and is associated with essential hypertension. Eur
J Hum Genet. 14:1295–1305. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Munoz-Planillo R, Kuffa P, Martínez-Colon
G, Smith BL, Rajendiran TM and Núñez G: K+ efflux is the common
trigger of NLRP3 inflammasome activation by bacterial toxins and
particulate matter. Immunity. 38:1142–1153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Marina-García N, Franchi L, Kim YG, Miller
D, McDonald C, Boons GJ and Núñez G: Pannexin-1-mediated
intracellular delivery of muramyl dipeptide induces caspase-1
activation via cryopyrin/NLRP3 independently of Nod2. J Immunol.
180:4050–4057. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chalmers J: The 1999 WHO-ISH guidelines
for the management of hypertension. Med J Aust. 171:458–459.
1999.PubMed/NCBI
|
|
17
|
Panyi G, Possani LD, Rodríguez de laVega
RC, Gáspár R and Varga Z: K+ channel blockers: Novel tools to
inhibit T cell activation leading to specific immunosuppression.
Curr Pharm Des. 12:2199–2220. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harrison DG, Marvar PJ and Titze JM:
Vascular inflammatory cells in hypertension. Front Physiol.
3:1282012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lewis RS: Calcium signaling mechanisms in
T lymphocytes. Annu Rev Immunol. 19:497–521. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Damjanovich S, Gáspár R and Panyi G: An
alternative to conventional immunosuppression: Small-molecule
inhibitors of Kv1.3 channels. Mol Interv. 4:250–254. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Leonard RJ, Garcia ML, Slaughter RS and
Reuben JP: Selective blockers of voltage-gated K+ channels
depolarize human T lymphocytes: Mechanism of the antiproliferative
effect of charybdotoxin. Proc Natl Acad Sci USA. 89:pp.
10094–10098. 1992; View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo J, Zhang YM, Ma KT, Si JQ and Liang P:
Difference in the expression of Kv channel in lymphocytes between
spontaneously hypertensive rats and Wistar rats. Sheng Li Xue Bao.
62:382–386. 2010.(In Chinese). PubMed/NCBI
|
|
23
|
Luo J, Ma KT, Zhang YM, Si JQ, Liang P and
Li J: Effects of telmisartan on 4-Aminopyridine-sensitive voltage
dependant potassium channel of lymphocyte derived from
spontaneously hypertensive rat. Zhonghua Xin Xue Guan Bing Za Zhi.
38:751–754. 2010.(In Chinese). PubMed/NCBI
|
|
24
|
Zhang Q, Zhang Y, Cheng L, Yuan Q, Zhang G
and Gou F: Effects of telmisartan on IKCa1 potassium channel after
T-lymphocyte activation and proliferation in peripheral blood of
hypertensive patients in Xinjiang Kazakh. Zhonghua Yi Xue Za Zhi.
94:182–186. 2014.(In Chinese). PubMed/NCBI
|
|
25
|
Koizumi Y, Toma C, Higa N, Nohara T,
Nakasone N and Suzuki T: Inflammasome activation via intracellular
NLRs triggered by bacterial infection. Cell Microbiol. 14:149–154.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schroder K and Tschopp J: The
inflammasomes. Cell. 140:821–832. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de Miguel C, Rudemiller NP, Abais JM and
Mattson DL: Inflammation and hypertension: New understandings and
potential therapeutic targets. Curr Hypertens Rep. 17:5072015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kawaguchi M, Takahashi M, Hata T, Kashima
Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J,
et al: Inflammasome activation of cardiac fibroblasts is essential
for myocardial ischemia/reperfusion injury. Circulation.
123:594–604. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pétrilli V, Papin S, Dostert C, Mayor A,
Martinon F and Tschopp J: Activation of the NALP3 inflammasome is
triggered by low intracellular potassium concentration. Cell Death
Differ. 14:1583–1589. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Leung G, Sun W, Brookes S, Smith D and Shi
R: Potassium channel blocker, 4-aminopyridine-3-methanol, restores
axonal conduction in spinal cord of an animal model of multiple
sclerosis. Exp Neurol. 227:232–235. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Panyi G, Varga Z and Gáspár R: Ion
channels and lymphocyte activation. Immunol Lett. 92:55–66. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ziesche R, Petkov V, Williams J, Zakeri
SM, Mosgöller W, Knöfler M and Block LH: Lipopolysaccharide and
interleukin 1 augment the effects of hypoxia and inflammation in
human pulmonary arterial tissue. Proc Natl Acad Sci USA. 93:pp.
12478–12483. 1996; View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nemati F, Rahbar-Roshandel N, Hosseini F,
Mahmoudian M and Shafiei M: Anti-inflammatory effects of
anti-hypertensive agents: Influence on interleukin-1β secretion by
peripheral blood polymorphonuclear leukocytes from patients with
essential hypertension. Clin Exp Hypertens. 33:66–76. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Barbieri M, Ferrucci L, Corsi AM, Macchi
C, Lauretani F, Bonafè M, Olivieri F, Giovagnetti S, Franceschi C
and Paolisso G: Is chronic inflammation a determinant of blood
pressure in the elderly? Am J Hypertens. 16:537–543. 2003.
View Article : Google Scholar : PubMed/NCBI
|
